Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study EP News Bureau Jul 25, 2024 Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Induced pluripotent stem cells show success in treating hemophilia A in mice EP News Bureau Mar 13, 2020 Cell therapy is actively being studied as a potential alternative therapy for haemophilia A In a new study released in STEM…
Haemophilia A and B treatment market value will reach $6.3 billion by 2024: GlobalData EP News Bureau Jan 6, 2016 The increase represents a tepid CAGR of 1.52 per cent across Argentina and the seven major markets of the US, France, Italy,…
